medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2009, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2009; 8 (2)


Prevalence of hepatitis C virus infection in patients with cardiomyopathy

Boyella V, Onyebueke I, Farraj N, Graham-Hill S, Younis CE, Bergasa NV

Idioma: Ingles.
Referencias bibliográficas: 24
Paginas: 113-115
Archivo PDF: 36.09 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore) 2000; 79(1): 47-56.

  2. DeCastro M, Sanchez J, Herrera JF, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993; 17(4): 551-7.

  3. Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 1994; 46(6): 1700-4.

  4. Jubert C, Pawlotsky JM, Pouget F, et al. Lichen planus and hepatitis C virus—related chronic active hepatitis. Arch Dermatol 1994; 130(1): 73-6.

  5. Ramos-Casals M, Garcia-Carrasco M, Cervera R, et al. Hepatitis C virus infection mimicking primary Sjogren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001; 80(1): 1-8.

  6. Matsumori A. Hepatitis C virus and cardiomyopathy. Herz 2000; 25(3): 249-54.

  7. Matsumori A, Ohashi N, Nishio R, et al. Apical hypertrophic cardiomyopathy and hepatitis C virus infection. Jpn Circ J 1999; 63(6): 433-8.

  8. Matsumori A, Ohashi N, Sasayama S. Hepatitis C virus infection and hypertrophic cardiomyopathy. Ann Intern Med 1998; 129(9): 749-50.

  9. Matsumori A, Ohashi N, Hasegawa K, et al. Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Jpn Circ J 1998; 62(5): 389-91.

  10. Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 1995; 92(9): 2519-25.

  11. Billingham ME, Tazelaar HD. The morphological progression of viral myocarditis. Postgrad Med J 1986; 62(728): 581-4.

  12. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99(8): 1091-100.

  13. O’Connell J. The role of myocarditis in end-stage dilated cardiomyopathy. Texas Heart Ins J 1987; 14: 268-275.

  14. Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 2000; 80(7): 1137-42.

  15. Teragaki M, Nishiguchi S, Takeuchi K, Yoshiyama M, Akioka K, Yoshikawa J. Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy. Heart Vessels 2003; 18(4): 167-70.

  16. Matsumori A, Shimada T, Chapman NM, Tracy SM, Mason JW. Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail 2006; 12(4): 293-8.

  17. Sanchez MJ, Bergasa NV. Hepatitis C associated cardiomyopathy: potential pathogenic mechanisms and clinical implications. Med Sci Monit 2008; 14(5): RA55-63.

  18. Prati D, Poli F, Farma E, et al. Multicenter study on hepatitis C virus infection in patients with dilated cardiomyopathy. North Italy Transplant Program (NITP). J Med Virol 1999; 58(2): 116-20.

  19. Reis FJ, Viana M, Oliveira M, Sousa TA, Parana R. Prevalence of hepatitis C and B virus infection in patients with idiopathic dilated cardiomyopathy in Brazil: a pilot study. Braz J Infect Dis 2007; 11(3): 318-21.

  20. Dos Reis FJ, de Sousa TA, Oliveira MS, et al. Is hepatitis C virus a cause of idiopathic dilated cardiomyopathy? A systematic review of literature. Braz J Infect Dis 2006; 10(3): 199-202.

  21. Iskandar SB, Loyd S, Downs CJ, Roy TM. Hepatitis C and dilated cardiomyopathy. Tenn Med 2004; 97(1): 31-3.

  22. Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res 2005; 96(2): 144-7.

  23. Shichi D, Kikkawa EF, Ota M, et al. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. Tissue Antigens 2005; 66(3): 200-8.

  24. McMurray J, Pfeffer M. Heart failure. The Lancet 2005; 365: 1877-1889.




2020     |     www.medigraphic.com